QuickView for CTNNB1;jsessionid=3CA831FEA6DBEDA7EE44CC58C4043ACE;jsessionid=8C29D5BDB326BCF77D274BB5A118433D;jsessionid=472FDC6B2F213E7CB9B164B789AB67EB (gene)

1. Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.
2. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder.
3. Localization of beta catenin across the domain of odontogenic lesions: A systematic review.
4. β-catenin inhibitors in cancer therapeutics: intricacies and way forward.
5. The possible role of Wnt/β-catenin signalling in vitiligo treatment.

There were no clinical trials for CTNNB1;jsessionid=3CA831FEA6DBEDA7EE44CC58C4043ACE;jsessionid=8C29D5BDB326BCF77D274BB5A118433D;jsessionid=472FDC6B2F213E7CB9B164B789AB67EB